- Merck (MRK, Financial) outperformed expectations in its latest earnings report, with non-GAAP earnings per share of $2.22, $0.08 higher than anticipated.
- The company's revenue also exceeded forecasts, reaching $15.5 billion, $170 million above expectations.
- Analysts predict a significant upside potential for Merck’s stock, with forecasted price targets suggesting a 40.02% increase, and the GF Value indicating a 53.59% upside.
Merck & Co (MRK) exhibited a robust performance in its recent earnings announcement, reporting a non-GAAP earnings per share of $2.22, which surpassed analyst expectations by $0.08. The company's revenue for the period also exceeded projections, reaching $15.5 billion, $170 million above the anticipated figures.
Wall Street Analysts Forecast
The one-year price targets from 22 analysts for Merck & Co Inc (MRK, Financial) present an average target price of $110.25, with estimates ranging from a high of $146.00 to a low of $89.00. This average target points to a potential upside of 40.02% from the current stock price of $78.74. For further details on these estimates, visit the Merck & Co Inc (MRK) Forecast page.
Analyzing the consensus recommendation from 27 brokerage firms, Merck & Co Inc's (MRK, Financial) average brokerage rating stands at 2.1, suggesting an "Outperform" status. In this scale, a rating of 1 indicates a Strong Buy, while a 5 represents a Sell recommendation.
According to GuruFocus estimates, the GF Value for Merck & Co Inc (MRK, Financial) projected for one year is $120.94. This suggests a significant upside of 53.59% from the current price of $78.74. The GF Value is GuruFocus's assessment of the fair value of a stock, calculated based on the historical trading multiples, past business growth, and future business performance projections. More comprehensive data are available on the Merck & Co Inc (MRK) Summary page.
